TGFB1 and metabolic dysfunction-associated steatotic liver disease: Literature mining has further revealed an inverse correlation between miR-122 and TGFβ1 levels in patients with liver diseases, including non-alcoholic fatty liver disease [58], primary biliary cholangitis [59], HCC [60], and viral hepatitis [61].